Genetic research will change forever the way we think of disease and aging, but with heavy expenses and long lead times, benefits to the bottom line are harder to predict.
Coca-Cola Amatil is still suffering from the performance of its division in the Philippines. While there is no sign of a quick fix, the company has been addressing the problem.